Showing 201 - 220 results of 2,913 for search '"The Real World"', query time: 0.10s Refine Results
  1. 201

    Wilson disease in the USA: epidemiology and real-world patient characteristics based on a retrospective observational health claims study by Karl Heinz Weiss, Peter Hedera, Shona Fang, Carey Strader, Halley Costantino

    Published 2024-12-01
    “…The 2017–2019 crude period prevalence was 21.2 patients per million (95% CI: 20.1 to 22.3), with similar prevalence observed for both sexes.Conclusions This study provides important real-world data on the diagnosed prevalence of WD in the USA and revealed the comorbidities associated with various disease subtypes, thereby providing a comprehensive basis for guiding physicians and policy makers in the management of this chronic disease.…”
    Get full text
    Article
  2. 202
  3. 203
  4. 204
  5. 205
  6. 206
  7. 207

    A Real-World, Multicenter Assessment of Drugs Requiring Weight-Based Calculations in Overweight, Adult Critically Ill Patients by Sandra L. Kane-Gill, Nicholas P. Wytiaz, Lisa M. Thompson, Karina Muzykovsky, Mitchell S. Buckley, Henry Cohen, Amy L. Seybert

    Published 2013-01-01
    “…The purpose of this study was to identify “real-world” dose ranges of high-risk medications administered via continuous infusion requiring weight-based dosing and determine the reasons for dosing changes (ineffectiveness or adverse drug reactions). …”
    Get full text
    Article
  8. 208
  9. 209

    Cost–Benefit Analysis of in vivo Reflectance Confocal Microscopy for Melanoma Diagnosis in a Real-World Clinical Setting by Bruno GM, Di Matteo S, Longo C, Stanganelli I, Farnetani F, Borsari S, Mazzoni L, Ciardo S, Raucci M, Magi S, Bassoli S, Spadafora M, Mandel VD, Casari A, Chester J, Kaleci S, Colombo GL, Pellacani G

    Published 2025-01-01
    “…The cost–benefit ratio for RCM was 3.89, meaning that for every € 1 spent on RCM, there is a benefit of € 3.89.Conclusion: In real-world clinical practice, adjunctive RCM offers significant economic advantages at local, regional, and national levels while maintaining patient safety and reducing unnecessary surgical procedures.Keywords: melanoma, dermoscopic examination, reflectance confocal microscopy, cost–benefit, economics, cost analysis, skin cancers…”
    Get full text
    Article
  10. 210
  11. 211
  12. 212

    Drug-induced dementia: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database by Lisi Xu, Ruonan Zhang, Xiaolin Zhang, Xiuli Shang, Daifa Huang

    Published 2025-01-01
    “…FDA Adverse Event Reporting System (FAERS) serves as an important resource for identifying real-world adverse drug reactions and safety signals. …”
    Get full text
    Article
  13. 213
  14. 214

    Real-world effectiveness of Semaglutide treatment on weight loss maintenance after weight loss in patients with obesity or overweight and diabetes by Michela Del Prete, Lidia Gavazzi, Olga Eugenia Disoteo, Federico Vignati, Gianleone Di Sacco, Fabrizio Muratori

    Published 2025-01-01
    “…Abstract Purpose To report data on the real-world effectiveness and safety of injectable (IS) and oral (OS) therapies in obese or overweight diabetes (T2DM) patients on glycometabolic control, weight loss (WL) and weight maintenance after the use of semaglutide. …”
    Get full text
    Article
  15. 215
  16. 216
  17. 217
  18. 218
  19. 219
  20. 220